SG
Superior Genomics, Inc.
SEC filingOther Technology · Norway, MI
Amount raised$508Ksold at filing
Total offering$1.5M$993K still open
Investors in the raise14count reported to the SEC
FiledAug 14, 2026first sale Jul 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David Van HollaExecutive Officer, Director
John Prista FreshleyDirector
Executive officers, directors and promoters as listed on the Form D.